A Modification of the American Joint Committee on Cancer Nomogram for Undifferentiated Sarcoma With External Validation and Risk Stratification
Authors:
- 31 October 2023
- journal article
- research article
- Published by SAGE Publications in The American Surgeon™
- Vol. 90 (4) , 762-769
Abstract
Background: The aim of this study is to establish a model to predict the overall survival (OS) and stratify the risk of postoperative patients with undifferentiated sarcoma. Methods: A total of 452 postoperative patients with undifferentiated sarcoma in the trunk and extremity from the Surveillance, Epidemiology, and End Results database were enrolled as the training cohort. We collected a group of 163 undifferentiated sarcoma patients from our center as the external validation cohort. Cox proportional hazards regression model was used to screen survival-associated factors for the construction of the nomogram. Concordance-indexes (C-indexes), calibration curves, and receiver operating characteristics (ROCs) curves were applied for the discrimination and calibration of the nomogram. The cutoff value of nomogram-based total points was applied to stratify the risk of patients. Results: A nomogram was developed incorporating four independent factors: age, tumor site, eighth AJCC stage, and radiotherapy. The nomogram showed good prognostic accuracy and excellent agreement in the training and validation cohort, with C-indexes of .701 (95% confidence interval [CI]: .683-.719) and .700 (95% CI: 0.659-.741), respectively. Furthermore, we identified the best cutoff value of nomogram total points (103.2) as the predicted risk and divided the patients into a high-risk group and a low-risk group. Significant differences in OS between the two groups were indicated in the training cohort and external validation cohort, showing the appreciable clinical validity and clinical utility of the nomogram ( P < .001). Conclusion: This nomogram provides an insightful and applicable tool for individual evaluations and the distinguishment of risk for patients with undifferentiated sarcoma.Keywords
Funding Information
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2021-I2M-C&T-B-054, 2021-I2M-C&T-B-053)
- Beijing Hope Run Special Fund of Cancer Foundation of China (No. LC2021A14)
- National Natural Science Foundation of China (No.82002848; No.82003397; No.82272964)
- Special Research Fund for Central Universities, Peking Union Medical College (No.3332022133)
- Fundamental Research Funds for the Central Universities (No. 3332021097)
This publication has 14 references indexed in Scilit:
- The genomics of undifferentiated sarcoma of soft tissue: Progress, challenges and opportunitiesSeminars in Cancer Biology, 2020
- Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20‐year experience of 266 casesAnz Journal of Surgery, 2019
- The pathology of soft tissue sarcomasLa radiologia medica, 2018
- Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centersCancer, 2017
- Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysisThe Lancet Oncology, 2016
- Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcomaJournal of Surgical Oncology, 2014
- An approach to pleomorphic sarcomas: can we subclassify, and does it matter?Laboratory Investigation, 2014
- MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st CenturyExpert Review of Anticancer Therapy, 2009
- MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities—an analysis of 140 patientsLangenbeck's Archives of Surgery, 2008
- Management of soft-tissue sarcomas: an overview and updateThe Lancet Oncology, 2000